New agents, new treatment, and antiemetic therapy
Author:
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (1) , 119-124
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice GuidelinesJournal of Clinical Oncology, 1999
- Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor AntagonistNew England Journal of Medicine, 1999
- Randomized Phase II Study of the Neurokinin 1 Receptor Antagonist CJ-11,974 in the Control of Cisplatin-Induced EmesisJournal of Clinical Oncology, 1999
- Double-blind, dose-finding study of four intravenous doses of dexamethasone in the prevention of cisplatin-induced acute emesis. Italian Group for Antiemetic Research.Journal of Clinical Oncology, 1998
- Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.Journal of Clinical Oncology, 1998
- Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.Journal of Clinical Oncology, 1998
- On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993Annals of Oncology, 1996
- Dexamethasone, Granisetron, or Both for the Prevention of Nausea and Vomiting during Chemotherapy for CancerNew England Journal of Medicine, 1995
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981